Tạp chí Tim mạch học Việt Nam
Genomic and proteomic technologies have become integral components of precision medicine, revolutionizing the field of cardiovascular disease management. These advanced technologies play a crucial role in enhancing scree...
**The American Heart Association (AHA)** annual scientific sessions have always been the largest international cardiovascular scientific event closing out each calendar year. AHA 2023, held in Philadelphia this past Nove...
Since the publication of the 2015 European Society of Cardiology (ESC) Guidelines for the management of infective endocarditis, important new data have been published mandating an update of recommendations. Therefore, in...
Cardiovascular risk stratification is an essential evaluation for physicians in tailoring specific treatment objectives for individual patients. SCORE2-Diabetes was developed to predict the 10-year risk of cardiovascular...
Background: Non-communicable diseases are one of the leading causes of death in Vietnam. This situation in North Vietnam has not been well documented for the last 10 years. Objective: to characterize patients admitted to...
Background: Pulmonary embolism (PE) is one of the three leading causes of cardiovascular mortality worldwide. In early 2026, the American Heart Association (AHA) and the American College of Cardiology (ACC), in collabora...
Cardiovascular disease during pregnancy is considered one of the major challenges of modern medicine because it directly affects the mother's life and profoundly impacts pregnancy outcomes and the long-term health of the...
Physical exercise has long been recognized as an effective non-pharmacological approach in the prevention and management of cardiovascular diseases. Numerous studies have demonstrated that regular physical activity provi...